According to a new report North America Pneumonia Testing Market, published by KBV research, the North America Pneumonia Testing Market would witness market growth of 7.9% CAGR during the forecast period (2020-2026).
The US market dominated the North America Immunodiagnostics Pneumonia Testing Market by Country 2019, and would continue to be a dominant market till 2026. The Canada market is experiencing a CAGR of 8.4% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 10.4% during (2020 - 2026).
The Diagnostic Centers market dominated the Canada Pneumonia Testing Market by End User 2019, growing at a CAGR of 6.9 % during the forecast period. The Hospitals market is exhibiting a CAGR of 8.8% during (2020 - 2026). Additionally, The HomeCare market is estimated to grow at the highest CAGR of 9.3% during (2020 - 2026).
The Analyzers market dominated the Mexico Pneumonia Testing Market by Type 2019, thereby, achieving a market value of $50.4 million by 2026, growing at a CAGR of 9.2 % during the forecast period. The Consumables market is expected to witness a CAGR of 12.1% during (2020 - 2026).
Full Report: https://www.kbvresearch.com/north-america-pneumonia-testing-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Meridian Bioscience Inc., Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific.
By Method
By End User
By Type
By Technology
By Country
Companies Profiled
Unique Offerings from KBV Research
Related Reports:
Global Pneumonia Testing Market
North America Pneumonia Testing Market
Unique Offerings 
